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Abstract
Helicobacter pylori is a major pathogen associated with the development of gastroduodenal diseases. It has been
reported that H. pylori induced pro-inflammatory cytokine IL1B is one of the various modulators of acid secretion in
the gut. Earlier we reported that IL1B-activated NFkB down-regulates gastrin, the major hormonal regulator of acid
secretion. In this study, the probable pathway by which IL1B induces NFkB and affects gastrin expression has been
elucidated. IL1B-treated AGS cells showed nine-fold activation of MyD88 followed by phosphorylation of TAK1 within
15 min of IL1B treatment. Furthermore, it was observed that activated TAK1 significantly up-regulates the NFkB
subunits p50 and p65. Ectopic expression of NFkB p65 in AGS cells resulted in about nine-fold transcriptional
repression of gastrin both in the presence and absence of IL1B. The S536A mutant of NFkB p65 is significantly less
effective in repressing gastrin. These observations show that a functional NFkB p65 is important for IL1B-mediated
repression of gastrin. ChIP assays revealed the presence of HDAC1 and NFkB p65 along with NCoR on the gastrin
promoter. Thus, the study provides mechanistic insight into the IL1B-mediated gastrin repression via NFkB.
Citation: Datta De D, Datta A, Bhattacharjya S, Roychoudhury S (2013) NF-kappaB Mediated Transcriptional Repression of Acid Modifying Hormone
Gastrin. PLoS ONE 8(8): e73409. doi:10.1371/journal.pone.0073409
Editor: Holger Bruggemann, Aarhus University, Denmark
Received July 20, 2012; Accepted July 24, 2013; Published August 23, 2013
Copyright: © 2013 Datta De et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This study was partially supported by research grants from the Indian Council of Medical Research (63/147/2001-BMS) and the Council of
Scientific and Industrial Research, India (IAP 001), awarded to SR. DDD and AD are supported by research fellowship form Council of Scientific and
Industrial Research, India. SB is supported by fellowship from University Grant Commission, India. The funders had no role in study design, data collection
and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
* E-mail: susanta@iicb.res.in
☯ These authors contributed equally to this work.
Introduction
About half of the world’s population harbors the gastric
pathogen Helicobacter pylori [1]. An interesting feature of H.
pylori mediated gastro-duodenal infection is the development of
a wide spectrum of diseases in infected individuals. While a
majority of the infected individuals remain asymptomatic, a fair
proportion develop gastritis, some of whom further progress to
either gastric ulcer, carcinoma or low grade B-cell lymphoma
[2]. While duodenal ulcer is characterized by increased acid
output, gastric cancer is associated with lower acid secretion
[3,4]. Gastrin is one of the major acid regulators in the gut [4]. It
is known that in response to an infection, the gastric mucosa
elicits an inflammatory response characterized by the release
of cytokines like IL1B, TNF-α etc [5]. In this context, we
previously described that IL1B polymorphism plays an
important role in H. pylori mediated duodenal ulcer and it
inhibits gastrin synthesis via Smad7 and NFkB pathway [6,7].
The exact mechanism by which IL1B down-regulates gastrin
through NFkB remains unknown. In the absence of appropriate
stimuli, the NFkB dimer (homodimer or heterodimers) is
sequestered by the IkB complex in the cytoplasm [8,9]. Upon
stimulation, an upstream signal, transduced primarily by
kinases (ERK/Protein kinases/ MAPK/JNK/p38/PI3K),
phosphorylates the IkB complex, leading to its degradation by
the ubiquitination pathway. This results in release of the
sequestered NFkB and its translocation to the nucleus to affect
gene transcription [10]. However, this well established model of
NFkB activation is not complete as reports suggest the
presence of NFkB in the nucleus of non-stimulated cells
[10–12]. These findings raise questions regarding the basal
transcriptional machinery of certain gene promoters involving
NFkB [12–15]. Moreover, the upstream signaling molecules
that release inactive NFkB from inhibitory IkB complex also
modify it by phosphorylation/acetylation at specific residues
[16–18]. Such modifications work as an imprint for NFkB to
further associate with co-regulators and ultimately affect gene
transcription [16–18]. There are many reports that suggest
association of certain co-regulators with specific modifications
on NFkB [19]. In this context, it is important to note the
emerging role of NFkB in transcriptional repression [11–13],
although it is primarily considered a transcriptional activator
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[20]. Many studies have reported that NFkB homodimers serve
as transcriptional repressors, justifying that these homodimers
lack the transactivation domain and bring about gene
repression. However, there are a few recent reports that
document NFkB heterodimers down-regulating gene
expression [11–13].
In this study we delineate the possible IL1B responsive
signaling pathway that activates NFkB and affects gastrin
expression. We further describe the role of the NFkB
heterodimer as a transcriptional repressor of gastrin expression
in the presence of IL1B, and also suggest its potential to
positively regulate the basal activity of the gastrin promoter. We
propose that NFkB can associate with different co-factors
producing opposing effects on the gastrin promoter.
Materials and Methods
Cell culture, transfection and treatment with IL1B, TSA,
NBD and siRNA
Human gastric cancer cell line AGS (CRL-1739,ATCC,USA)
was maintained in RPMI 1640 medium (Invitrogen, Carlsbad,
CA, USA) supplemented with 10% fetal calf serum (Invitrogen,
Carlsbad, CA, USA) and antibiotics (1% Pen Strep and 0.006%
Gentamicin, Invitrogen, Carlsbad, CA, USA) at 370C in 5% CO2
incubator (Innova Co-170, New Brunswick Scientific, India).
AGS cells plated in 35mm dish (0.5×106) were transiently
transfected in duplicates with different amounts of DNA as
required for the specific experiment using Lipofectamine 2000
Reagent (Invitrogen, Life Technologies, Carlsbad, USA)
according to the manufacturer’s protocol. PGL3 control vector
(Promega, Madison, USA) was used as control for luciferase
assay. To account for variable transfection efficiency between
samples, cells were co-transfected with the β-gal expressing
reporter plasmid pSV- β -Galactosidase Control Vector
(E-1081, Promega, Madison, USA). AGS cells were treated
either with varying amounts (0–10 ng/ml) of recombinant IL1B
(Sigma Aldrich, St. Louis, USA) for two and a half hr or with
10ng/ml recombinant IL1B for different time points. Twenty-four
hr after transfection, AGS cells were incubated with 150 µM of
nemo binding inhibitory peptide (NBD) (Calbiochem-
Novabiochem, San Diego, USA) for additional 24 hr and
harvested for luciferase assay. AGS cells transfected with 240
Gas-Luc were treated with Trichostatin A (Calbiochem-
Novabiochem, SanDiego, CA), a histone deactylase inhibitor,
at 100 nM for 48 hr and harvested for further experiments. The
siRNA directed against TAK1 (Santa Cruz Biotechnology, CA),
p300 (Ambion, Life Technologies, Foster City, USA) and
control scrambled siRNA (Ambion, Life Technologies, Foster
City, USA) were used at a final concentration of 80 nM for 48
hr. All treatments except the transfections were performed at
10% serum containing medium.
Quantitative Real Time PCR
Total cellular RNA was extracted from recombinant IL1B
treated AGS cells by Trizol method according to the
manufacturer’s protocol (Invitrogen, Life Technologies,
Carlsbad, USA). cDNA was prepared using random hexamer
(Invitrogen, Life Technologies, Carlsbad, USA) with MMLV RT
(Promega, Madison, USA). Relative mRNA expression was
determined by real time RT PCR in the ABI 7500 Fast or
StepOne (Applied Bio-systems Inc, Life Technologies, Foster
City, USA) using the SYBR Green technology (Applied
Biosystems Inc, Life Technologies, Foster City, USA). The
primer pairs used are as follows: MyD88 forward(F) 5’-
CGGCAACTGGAGACACAAG-3’ and MyD88 reverse (R) 5’-
TCTGGAAGTCACATTCCTTGC-3’; Beta-actin forward (F) 5′-
GGATGCAGAAGGAGATCACTG-3′ and Beta-actin reverse
(R) 5′-CGATCCA CACGGAGTACTTG-3′; TAK1 forward(F) 5′-
CAGAGCAACTCTGCCACCAGTA-3 ′and TAK1 reverse (R) 5′-
CATTTGTGGCAGGAACTTGCTCC-3′; p300 forward(F) 5′-
TAAACTCTCATCTCCGGCCC-3 ′and p300 reverse (R) 5′-
CCACCATTGGTTAGTCCCAA-3′; 18srRNA forward (F) 5′-
TGACTCTAGATAACCTCGGG-3′ and 18srRNAreverse (R) 5′-
GACTCATTCCAATTACAGGG-3′. Threshold cycle CT of
duplicate samples was determined using the ABI 7500 Fast or
StepOne software (Applied Biosystems Inc, Life Technologies,
Foster City, USA). The expression of target genes were
normalized to Beta–actin or 18srRNA levels by calculating the
ΔCT value which is defined as CT (threshold cycle) of the
endogenous control subtracted from the CT of the target genes.
The fold differences of target gene expression were calculated
using the formula 2 –ΔΔCT.
Western Blot analysis
IL1B treated AGS cells (2.0×106 cells) were subjected to
western blot analysis using antibodies against TAK1(1:500
dilution, #4505, Cell Signaling, USA), p-TAK1(1:100 dilution,
#4536, Cell Signaling, USA), TAB1(1:500 dilution, #3226, Cell
Signaling, USA) NFkB p50 antibody (1:500 dilution, #3035, Cell
Signaling, USA), NFkB p65 antibody(1:500 dilution,
Sc-7151,Santa Cruz Biotechnology Inc, Santa Cruz, USA and
#6956, Cell Signaling, USA), NFkB phosphop65S536
antibody(1:100 dilution, Santa Cruz Biotechnology Inc, Santa
Cruz, USA), or Beta -actin (Sigma Aldrich, St. Louis, USA). The
immune complexes were detected by staining with HRP-
conjugated secondary antibody (Sigma Aldrich, St. Louis,
USA). The band intensities were quantified by using ImageJ
(http://rsb.info.nih.gov/ij/index.html). The integrated density of
each band was normalized to the corresponding human Beta-
actin band.
Luciferase and β-galactosidase Assay
The cells were lysed in the luciferase cell culture lysis buffer
provided with the Luciferase Assay Kit (Promega, Madison,
USA) and 15 µl of supernatant was analyzed for firefly
luciferase activity. Luminescence was measured as relative
light units (RLU), taking the reading of luciferase assay
substrate alone and then with lysate in GlowMax 20/20
luminometer (Promega, Madison, USA). The total protein
concentration in each lysate was determined by a protein
assay kit (Sigma Aldrich, St. Louis, USA) and subsequently
used to normalize the luciferase activity. Transfection
normalization was done by beta galactosidase assay. β-gal
assay was performed using β-gal assay kit according to the
manufacturer’s protocol (Promega, Madison, USA). Luciferase
activity was normalized with the corresponding β-gal activity
NFkB Transcriptionally Repress Gastrin
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and expressed as relative light unit/µg of protein.
Measurements of mean ± S.D of relative luciferase unit per
microgram of protein were taken in triplicates and represented
graphically as mean ±S.D on a MS-Excel sheet.
Co-immunoprecipiation Assay
Recombinant IL1B (10ng/ml) treated and untreated AGS
cells were washed with PBS and the pellet was resuspended in
200 mM NaCl, 20 mM Tris-HCl (pH 7.5), 1% Triton X-100, 1
mM DTT, and Protease Inhibitor Cocktail (Sigma Aldrich, St.
Louis, USA). The cells were lysed by freeze-thaw cycle and the
supernatant was treated overnight with either anti-HDAC1 or
anti-p300 antibody (Santacruz Biotechhnology, Santacruz,
USA). Rabbit normal IgG (Sigma Aldrich, St. Loius, USA) was
taken as a control for immunoprecipitation. The antibody
protein complex was precipitated with Protein-G sepharose
beads (Genei, Bangalore, India), washed and eluted by SDS-
lysis buffer. The eluted sample was then processed for western
blot analysis with anti NFkB p65 antibody.
Electrophoretic Mobility Shift Assay (EMSA)
IL1B treated AGS cells (8.2 X 106 cells) were harvested in
1ml of ice-cold PBS and washed with hypotonic buffer (10mM
Hepes pH 7.9, 1.5mM MgCl2, 10mM KCl, 0.5mM PMSF and
0.5mM DTT) by centrifuging at 10,000 rpm for 5 min at 4oC.
Washed cells were resuspended in hypotonic buffer containing
0.5% NP-40 and centrifuged at same speed. The nuclear pellet
thus obtained was lysed in lysis buffer (20mM Hepes pH 7.9,
420mM NaCl, 1.5mM MgCl2, 0.2mM EDTA, 25% glycerol,
0.5mM PMSF) and centrifuged at 14,000 rpm for 10min at 40C.
The supernatant nuclear extract was mixed with storage buffer
(10mM Hepes pH 7.9, 50mM KCl, 0.2mM EDTA, 20%(v/v)
glycerol, 0.5mM PMSF, and 0.5mM DTT) and kept at -80oC for
further use. Protein concentrations of the nuclear extracts were
determined by Bradford method (Sigma- Aldrich, St.Loius,
USA). The oligos (at equal concentration) of the putative NFkB
site on gastrin promoter are sense: 5’-
TGACCCCCAGGATATGGTGGG-3’ and antisense: 5’-
ACTGGGGGTCCTATACCACCC-3’ [NT_086877, GeneID:
2520] and that of consensus NFkB binding sites are sense: 5’-
AGTTGAGGGGACTTTCCCAGGC-3’ and antisense: 5’-
GCCTGGGAAAGTCCCCTCAACT-3’. The annealed oilgos
were labeled with (γ-32P) dATP using T4 polynucleotide kinase
(Promega, Madison, USA). Gel supershift assay was
performed by incubating the nuclear lysates prepared from
AGS cells either with NFkB p50 (ab7971, Abcam,
Cambridge,USA) or NFkB p65 antibody (ab7970, Abcam,
Cambridge, USA) for 30 minutes followed by addition of the
radio-labelled gastrin promoter probe. After incubation the
samples were immediately loaded on to a 5% nondenaturing
polyacrylamide gel and run at 200 V for 2 hr. Gel was dried and
exposed to X-ray film.
Chromatin Immunoprecipitation Assay (ChIP)
Chromatin immunoprecipitation (ChIP) assay was performed
according to the protocols for Imgenex Quick Chip Kit
(Imgenex, CA, USA). AGS cells were either treated with IL1B
(10ng/ml) or left untreated and harvested after two and a half
hr. Cells were resuspended in lysis buffer and sonication was
performed to obtain 200-1000bp DNA fragments. The sheared
DNA was then cleared off debris and immunoprecipitation was
performed at 4°C overnight with anti NFkB p50 (ab7971,
Abcam, Cambridge,USA), anti NFkB p65 (ab7970,Abcam,
Cambridge,USA), anti NCoR (ab24552,Abcam, Cambridge,
USA), anti HDAC1 (Santa Cruz Biotechnology Inc. Santa Cruz,
USA), anti H3K9Me3 (ab8898, Abcam, Cambridge, USA), and
anti p-300 antibody (N15, sc584, Santa Cruz Biotechnology
Inc, Santa Cruz, USA). Subsequently the immunoprecipitated
DNA was assayed by quantitative Real Time PCR using
Gastrin forward (F) 5’-AAGCATTGCTCCTGACCCAG-3’,
Gastrin reverse (R) 5’- ACCCTGCCATATGAGTCCAG-3’
primer pairs in ABI StepOne (Applied Bio-systems Inc, Life
Technologies, Foster City, USA) with SyBR Green (Applied
Bio-systems Inc, Life Technologies, Foster City, USA)
technology for promoter occupancy. Primers against GAPDH
promoter (GAPDH forward: 5’-
AAAAGCGGGGAGAAAGTAGG-3’, GAPDH reverse: 5’-
AAGAAGATGCGGCTGACTGT-3’) were used as negative
control. Data was plotted in MS Excel as a percentage of input
from mean of three different experiments performed.
ELISA
AGS cells (0.5X106) were plated in 35mm dish and either
treated with IL1B (10ng/ml) or left untreated for 2 hr. The cell
lysates were prepared and protein estimation was done by
Bradford reagent (Sigma Aldrich, St. Louis, USA) as per the
manufacturer’s protocol. Equal amount of protein lysates were
analyzed for gastrin (gastrin-17 polypeptide) protein using
Gastrin Immunoassay kit (Assay Design Inc, Ann Arbor, USA)
according to the manufacturer’s protocol.
Results
IL1B activates NFkB through TAK1 to inhibit gastrin
expression
Chakravorty et al. previously established that IL1B-
stimulated expression of NFkB leads to down-regulation of the
gastrin promoter, indicating NFkB as a repressor of gastrin
transcription [6]. However, the specific pathway by which IL1B
induces NFkB and down-regulates gastrin remains largely
unknown. IL1B recognizes its cognate receptor IL1R, and
initiates a cascade of signaling events that involves different
adaptor proteins. Myeloid differentiation factor 88 (MyD88) is
one such widely utilized adaptor molecule in IL1R signaling
[21]. We observed a dose dependent increase in MyD88
mRNA in AGS cells upon treatment with IL1B for 15 min
(Figure 1A). MyD88 subsequently interacts with other receptor
associated protein kinases that ultimately impinge on TAK1
(transforming growth factor β-activated kinase 1) and activates
the transcription factor NFkB (p50/p65) [22]. However, MyD88
dependent activation of NFkB can also be induced by TAK1
independent pathways, as reported in TAK1 deficient murine
embryonic fibroblasts, where incomplete suppression of IL1R
or LPS-induced NFkB activation was observed [23]. We had
reported that pharmacological inhibitors of possible signaling
pathways, like PD-98059 for ERK and SB-202190 for p38
NFkB Transcriptionally Repress Gastrin
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MAPK, do not have significant effects on gastrin repression by
IL1B [6]. It was also not found to be significantly affected by
kinase inhibitors like phosphokinase A inhibitor (H89),
phoshotyrosine kinase inhibitor (Genestin), phospholipase C
inhibitor (Neomycin Sulphate), phosphokinase C inhibitor
(Staurosporine) [6]. Thus, we investigated the role of TAK1 in
IL1B mediated activation of NFkB in AGS cells. AGS cells were
treated with 10ng/ml IL1B and harvested at different time points
(as described in Figure 1B) to detect phosphorylated TAK1 by
western blot analysis. As stimulation by recombinant IL1B is
transient, phosphorylation of TAK1 peaked at 15 min of
treatment and the signal reduced at 30 min (Figure 1B). There
was no change in the level of total TAK1 protein upon IL1B
treatment (Figure 1B).
We next investigated whether IL1B-activated TAK1 is able to
induce NFkB and inhibit gastrin expression. AGS cells were co-
transfected with increasing doses of pCMVTAK1 and
pCMVTAB1. TAB1, a mammalian TAK1 adaptor protein,
interacts constitutively with TAK1 and induces TAK1 kinase
activity when over-expressed [24]. We observed ~4 fold (Figure
1C, lower panel and histogram) and ~5 fold (Figure 1C upper
panel and histogram) activation of p65 and p50, respectively, at
the highest concentration of transfected pCMVTAK1 (Figure
1C). Overexpression of pCMVTAK1 and pCMVTAB1 has been
shown in Figure S1A. To validate that activated TAK1 was
indeed the molecular intermediate between IL1B and NFkB for
gastrin repression, AGS cells were co-transfected with pGas-
Luc, pCMVTAK1 and pCMVTAB1, and luciferase assay was
performed after 48 hr of transfection. We observed that
increasing concentrations of either pCMVTAK1 (Figure 1D) or
pCMVTAB1 (Figure 1E) repressed gastrin promoter activity in a
dose-dependent manner. To ensure that TAK1 was involved,
AGS cells were co-transfected with pGas-Luc and siRNA
against TAK1 for 46 hr, treated with recombinant IL1B
(10ng/ml) for 2 hr, and a luciferase assay was performed. We
found that knock down of TAK1 by specific siRNA was able to
alleviate the down-regulation of gastrin by IL1B (Figure 1F and
Figure S1B), supporting the role of TAK1 in regulation of the
gastrin promoter. Thus, these experiments indicate that IL1B
induced TAK1 activates NFkB (p50/p65) to down- regulate
gastrin (Figure 1G).
IL1B-dependent post-translational modifications of
NFkB p65 influence gastrin repression in AGS cells
Activation of NFkB involves modifications (phosphorylation,
acetylation, sumoylation and ubiquitination) on specific
residues that determine both the strength and duration of the
NFkB-mediated transcriptional response [25]. We observed
that pWTp65 NFkB, when transfected in AGS cells, was able to
repress gastrin expression both in the presence and absence
of IL1B (Figure 2A). To further dissect the mechanism of NFkB
p65-mediated gastrin repression, the effects of various NFkB
p65 mutants were studied (Figure 2B and Figure 2C). The
transcriptional repression activity of various lysine mutants of
NFkB p65 (K310R p65 NFkB, K221R p65 NFkB) remained
unchanged both in the presence and absence of IL1B on the
pGas-Luc promoter, suggesting that acetylation at these sites
is not involved in NFkB-mediated inhibition of gastrin
expression (Figure 2B). However, the transcriptional repression
activity of the S536A mutant of NFkB p65 on the pGas-Luc
promoter was significantly abrogated both in the presence and
absence of IL1B in AGS cells (Figure 2C). In contrast, the
inhibitory activities of pS276Ap65 NFkB and pS529Ap65 NFkB
were comparable to that of pWTp65 NFkB suggesting that
these sites are not involved in the transcriptional repression of
gastrin (Figure 2C). There was ~1.8 fold repression of gastrin
luciferase in presence of pS536Ap65 NFkB in contrast to 9 fold
repression by pWTp65 NFkB (Figure 2C). We also show IL1B-
induced specific phosphorylation at serine 536 residue of wild
type NFkB p65 in a dose dependent manner (Figure 2D).
These results suggest that IL1B- induced S536
phosphorylation of NFkB is responsible for transcriptional
repression of gastrin expression.
NFkB along with HDAC1 negatively influences the
gastrin promoter in AGS cells
In a previous study we observed that IL1B-mediated gastrin
repression was abrogated by the HDAC inhibitor TSA [6].
However, the molecular mechanism underlying this inhibition
was not investigated. As HDACs are a major class of chromatin
modifying proteins that influence NFkB transcription [26], we
tested the possibility that HDAC proteins may be involved in
the NFkB-mediated repression of gastrin transcription. Co-
transfection of pHDAC1 and pGas-Luc in AGS cells resulted in
dose dependent inhibition of gastrin promoter activity by
HDAC1 protein (Figure 3A). Interestingly, both NFkB p65 and
HDAC1 mediated gastrin promoter repression was significantly
alleviated in the presence of TSA and NBD (NFkB inhibitor),
respectively (Figure 3B). Moreover almost complete alleviation
was observed when both TSA and NBD were present together
(Figure 3B). These results suggest that the interaction between
HDAC1 and NFkB p65 is required for the repression of gastrin
expression by NFkB. To further confirm that the interaction
between NFkB p65 and HDAC1 is necessary for gastrin
repression, we compared the gastrin promoter activity in AGS
cells co-transfected with pHDAC1 and either WTp65NFkB or
the pS536Ap65NFkB mutant. Figure 3C clearly shows that the
inhibitory activity of HDAC1 was significantly abrogated in the
presence of the S536A mutant when compared to its
association with wild type NFkB p65. It should be noted,
however, that pS536Ap65NFkB did affect gastrin expression to
a lesser extent. Finally, co-immunoprecipitation analysis
demonstrates that HDAC1 physically interacts with NFkB p65
more efficiently in the presence of IL1B while there is reduced
interaction between NFkB p65 and p300 under the same
condition (Figure 3D and 3E).
IL1B-dependent HDAC1 and NCoR recruitment at the
gastrin promoter results in gastrin repression by
histone modifications
Binding of NFkB subunits on the gastrin promoter was
validated by EMSA using probes designed either from the
putative NFkB binding site on the gastrin promoter, or from the
consensus NFkB site (Figure 4A and Figure S2A). Gastrin
promoter occupancy of NFkB was further confirmed by a ChIP
qPCR assay in AGS cells in the presence and absence of IL1B
NFkB Transcriptionally Repress Gastrin
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Figure 1.  IL1B-induced TAK1 activates NFkB to inhibit gastrin expression.  (A) Dose dependent activation of MyD88 by IL1B
in AGS cells. Total RNA was extracted from AGS cells treated with increasing concentration of recombinant IL1B (0, 5, 10ng/ml) for
10 min. Real time PCR analysis for MyD88 was performed in those RNA samples. β-actin was taken as the endogenous control.
The graph represents the mean of relative quantification measured from three different experiments +/- SD. (B) Analysis of IL1B
induced phosphorylation of MAP3K TAK1. AGS cells were treated with 10ng/ml recombinant IL1B protein for 0, 15 and 30 min and
then lysed for western blot analysis with p-TAK1, TAK1 and β–actin antibodies. A representative blot is shown. The band intensities
were scanned by imageJ and the normalized mean band intensities of three independent experiments with +/-SD values graphically
plotted. (C) Dose dependent activation of NFkB p50 and p65 by TAK1. AGS cells were co-transfected in a dose dependent manner
with pCMVTAK1 along with its activator pCMVTAB1 and western blot analysis was done for NFkB p50 and p65 respectively. A
representative blot is shown. The band intensities were scanned by imageJ and the normalized mean band intensities of three
independent experiments with +/-SD values graphically plotted. (D and E) Effect of TAK1/TAB1on gastrin promoter activity. AGS
cells were co-transfected with gastrin luciferase (pGAS-Luc) and either with (D) varying concentrations of pCMVTAK1 along with 0.2
µg of pCMVTAB1 or (E) varying concentrations of pCMVTAB1 along with 0.5 µg of pCMVTAK1.The IL1B (10ng/ml) treatment as
control has been included in panel E. Cells were harvested after 48 hr of transfection for luciferase assay. The normalized mean
Relative Luciferase Unit/µg protein +/- SD of three different experiments was plotted. (F) Knock down of TAK1 in IL1B-treated AGS
cells releases gastrin repression. AGS cells were first transfected with either TAK1 siRNA (80 nM) or control siRNA(80 nM). After
twenty four hr these cells were transfected with 0.5 µg of pGAS-Luc.Forty six hr post pGAS-Luc transfection, cells were treated with
IL1B (10ng/ml) for two hr and subsequently harvested. Control experiments with only pGAS-Luc transfected and IL1B treated
pGAS-Luc transfected AGS cells are also shown. (G) A cartoon showing that IL1B induces NFkB via MyD88/TAK1 to regulate
gastrin expression. Stars in panel C indicate statistical significance of the observations.
doi: 10.1371/journal.pone.0073409.g001
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Figure 2.  IL1B represses gastrin promoter by inducing S536 phosphorylation of NFkB p65.  (A) Effect of NFkB p65 on gastrin
promoter activity. AGS cells were co-transfected with gastrin luciferase (pGAS-Luc) along with 0.2µg of NFkB p65 (pWTp65NFkB).
Forty six hr after transfection, cells were either treated or left untreated with 10ng/ml of IL1B for two hr and then harvested for
luciferase assay. The normalized mean Relative Luciferase Unit/µg protein +/- SD of three different experiments was plotted. (B and
C) Effect of NFkB p65 mutants on gastrin promoter activity. AGS cells were co-transfected with gastrin luciferase (pGAS-Luc) along
with (B) either NFkB p65 (pWTp65NFkB) or the lysine NFkB p65 mutants (pK310R p65 NFkB and pK221R p65 NFkB) and (C) with
either NFkB p65 (pWTp65NFkB) or with the serine NFkB p65 mutants (pS536A p65 NFkB, pS529A p65 NFkB and pS276A p65
NFkB). Forty six hr after transfection, cells were either treated or left untreated with 10 ng/ml of IL1B for two hr and then harvested
for luciferase assay. 0.2µg of wild type or mutant NFkB p65 were used for transfection. The normalized mean Relative Luciferase
Unit/µg protein +/- SD of three different experiments was plotted. (D) Analysis of IL1B induced phosphorylation of NFkB p65 at
ser536 residue. AGS cells were treated with varying concentrations of recombinant IL1B protein for two hr and then lysed and
immunoblotted with anti p-p65NFkB (S536) and anti α-tubulin antibodies. A representative blot is shown. The star in panel C
indicates that the repression of transcription of pGAS-Luc with pWTp65NFkB is significantly alleviated when p65S536ANFkB was
used both in presence and absence of IL1B.NS indicates that the differences between the repressive activity of pWTp65NFkB and
that of the mutant clones on gastrin promoter are not significant.
doi: 10.1371/journal.pone.0073409.g002
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Figure 3.  HDAC1 associates with NFkB to repress gastrin promoter activity.  (A) Effect of HDAC1 on gastrin promoter activity.
AGS cells were co-transfected with pGAS-Luc construct and increasing amount of HDAC1 expression vector. Cells were harvested
48 hr after transfection and luciferase activity was measured. The mean luciferase activity of three different experiments +/- SD is
graphically plotted. (B and C) Combined effect of NFkB p65 and HDAC1 on gastrin promoter activity. (B) AGS cells were co-
transfected with pGAS-Luc construct along with pHDAC1 or pWTp65NFkB or both. Transfected cells were then incubated with
either NBD (150µM) for 24 hr or TSA (100nM) for 48 hr or both or left untreated. Cells were harvested after 48 hr of transfection.
The mean luciferase activity of three different experiments is represented as fold repression with respect to gastrin promoter alone
and graphically plotted. (C) AGS cells were co-transfected with pGAS-Luc in combination with either pWTp65NFkB or pS536A p65
NFkB with and without pHDAC1 expression vector. Cells were harvested after 48 hr of transfection. The mean luciferase activity of
three different experiments is represented as Relative Luciferase Unit/µg protein with respect to gastrin promoter alone and
graphically plotted. (D) Co-immunoprecipitation assay confirms the association of NFkB p65 with either p300 or HDAC1 in IL1B
stimulus specific manner. AGS cells were either treated with 10ng/ml of recombinant IL1B or left untreated for two hr. Lysates were
prepared for immunoprecipitation with either p300 or HDAC1. Immunoprecipitated protein complexes were then immunoblotted with
NFkB p65 antibody. (E) The band intensities of co-immunoprecipitation experiments were scanned by imageJ and their mean
normalized density of three independent experiments with +/-SD values graphically plotted.
doi: 10.1371/journal.pone.0073409.g003
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(Figure 4B). GAPDH promoter occupancy was monitored as a
negative control in all ChIP qPCR experiments (Figures S2B
and S2C). It may be reasoned that the presence of NFkB
subunits on the gastrin promoter under the untreated condition
can be attributed to basal gastrin expression. Next, we
investigated the possible association of co-activators and co-
repressors with NFkB on the gastrin promoter in the presence
and absence of IL1B. We found that under the untreated
condition, NFkB p65 co-immunoprecipitated with histone
acetylase p300 (Figure 3D). The presence of p300 was also
observed on the gastrin promoter along with NFkB subunits in
un-stimulated cells (Figure 4B). In IL1B-stimulated cells,
however, there was little change in the recruitment of p300 in
contrast to significantly increased molecular abundance of
HDAC1 on the gastrin promoter (Figure 4B). To further dissect
the mechanism, we measured the endogenous gastrin-17 level
under the following conditions: (a) AGS cells transfected with
siRNA against p300 in the absence of IL1B and (b) AGS cells
treated with HDAC inhibitor TSA in the presence of IL1B. We
observed that knockdown of p300 resulted in decreased
endogenous gastrin levels in AGS cells (Figure 5A), as
expected. On the other hand, inhibition of HDAC1 activity by
TSA led to the partial release of IL1B-mediated gastrin
repression (Figure 5B). Figure S3 depicts that siRNA against
p300 substantially lowered p300 mRNA expression in AGS
cells (Figure S3). These results indicate that there is a change
from the basal transcription activation mode (due to the
presence of p300) to a repression mode upon stimulation by
IL1B, which promotes the association of NFkB p65 with
HDAC1 (Figure 5C). It is known that HDAC1 is involved in
transcriptional repression by forming complexes with other
repressor molecules such as mSin3 and NCoR [27]. Thus, the
recruitment of these co-repressors on the gastrin promoter was
investigated in the presence of IL1B by ChIP. Our results show
that along with HDAC1, there was also recruitment of NCoR on
the gastrin promoter in the presence of IL1B (Figure 4C).
Recruitment of such repressor complex is followed by histone
modifications. Methylation at the lysine 9 of histone 3
(H3K9Me3) is widely recognized as a signature of gene
repression [20]. The gastrin promoter was checked for such
signatures in AGS cells treated with recombinant IL1B (10ng/
ml). Figure 4C shows the presence of methylated histone at the
gastrin promoter in the presence of IL1B. These results
suggest that IL1B recruits NFkB along with HDAC1 and NCoR
to bring about gastrin repression via histone methylation.
Discussion
In this study we have elucidated the signaling events that
lead to IL1B-mediated repression of gastrin expression through
NFkB activation in gastric carcinoma cells. We have
investigated the mechanism by which the NFkB p65 subunit
alters from activator mode to repressor mode in response to
IL1B. IL1B-mediated NFkB activation might involve a number
of MAP kinase pathways [28]. Antagonistic studies using
pharmacological molecules indicated that IL1B does not
transduce signal through the ERK, JNK, p38, and other protein
kinase pathways to exert its effect on gastrin. On the contrary,
this study delineated that IL1B-mediated down-regulation of
gastrin is achieved by NFkB activation via the MyD88-TAK1
pathway (Figure 1G and [6]).
In cells, NFkB exists as a heterodimer comprised primarily of
p50 and p65 protein subunits [8,9]. In the absence of activating
signals, NFkB is sequestered in the cytoplasm by the inhibitor
protein IkBα. Biological signals that induce phosphorylation of
IkBα release the sequestered NFkB, allowing it to translocate
to the nucleus and affect gene transcription [8,9,29]. Also, the
p65 subunit of NFkB is known to be phosphorylated [30] by
upstream kinases in response to a number of different stimuli,
which may modulate the interaction of p65 with co-activator
and co-repressor proteins [30]. In our study, the transcriptional
potential of different mutant NFkB p65, with defects in the
commonly known posttranslational modification sites, was
investigated with respect to gastrin expression. The S536A
phosphorylation mutant was shown to alleviate IL1B-mediated
gastrin repression. Interestingly, we also observed that there
was IL1B-induced phosphorylation of NFkB p65 at the S536
residue. It has been reported that phosphorylation at S536
increases the DNA binding ability of p65 and thus influence its
transcriptional activity [19]. Though, to date, the S536
phosphorylation of NFkB p65 has been thought to be
associated with transcriptional activation of the gene [31–34],
our results indicate that IL1B-induced phosphorylation at S536
of NFkB p65 stabilizes the protein-DNA complex, and thereby
helps sustain the inhibitory action of IL1B. We also observed
that even in un-stimulated cells, the S536A mutant does not
significantly repress gastrin compared to wild type NFkB p65.
This observation emphasizes the importance of the S536
residue in the inhibition of gastrin expression, and suggests
that the S536A mutant probably has lower DNA binding affinity
than the wild type NFkB p65.
Gene transcription is a dynamic process governed by the
extent and level of histone activity at a given promoter. Among
the most studied histone modifications known to influence gene
transcription is histone acetylation, which is governed by the
balanced activities of histone acetylases (HATs) and
deacetylases (HDACs) [35]. Class I HDACs, which include
HDAC1, HDAC2, HDAC3, and HDAC8, are recruited to DNA
as part of a large multiprotein repressor complex comprised of
Sin3 or Mi-2-NuRD proteins [27]. One paradigm supports that
HDACs inhibit gene transcription by deacetylating histone core
proteins [26], which compacts the nucleosome, sterically
impairing access of transcription factors to DNA [20,35]. In
addition to histone modification, HDACs can also influence
gene transcription by modifying non-histone DNA binding
factors as well. Indeed, HDACs have been reported to impair
gene transcription by interacting with certain transcription
factors [36,37]. Likewise, in this study we show that the HDAC
inhibitor TSA alleviates the inhibitory activity of NFkB p65 on
gastrin gene transcription. Furthermore, over-expression of
HDAC1 alone, as well as in the presence of wild type NFkB
p65, resulted in increased inhibition of gastrin. Interestingly,
there was alleviation of HDAC1-mediated repression in the
presence of the NFkB inhibitor, NBD, which suggests that
inhibition by HDAC1 is dependent on the presence of wild type
NFkB p65. Indeed, co-immunoprecipiation confirmed the
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association of p65 with HDAC1 in IL1B-treated cells. Thus,
these results suggest that the association of NFkB and HDAC1
brings about transcriptional repression of gastrin. Since over-
expression of HDAC1 with S536Ap65NFkB did not repress
gastrin expression as strongly as the case of the wild type, we
conclude that the DNA binding ability of p65 is important in
bringing about gene repression. Thus, our study highlights a
less defined but emerging role for NFkB as a transcriptional
repressor [38,39].
We observed the presence of NFkB heterodimers on the
gastrin promoter both in IL1B stimulated and un-stimulated
cells. The function of this nuclear NFkB in un-stimulated cells is
not clear, although we presume that it may be involved in
regulating basal gene expression. The reduced promoter
activity upon deletion of the NFkB site from gastrin promoter
led us to investigate a possible positive role of NFkB in basal
gene transcription. Gene transcription is known to be regulated
by transcription factors in association with various co-regulatory
(co-activator and co-repressor) proteins [11]. These co-
Figure 4.  NFkB hetero-dimerize on the gastrin promoter and associate with either p300 or HDAC1 in a stimulus specific
manner.  (A) Direct binding of NFkB heterodimers to gastrin promoter. EMSA was performed with nuclear extracts prepared from
IL1B treated (10ng/ml for 2hr.) AGS cells. Supershift assay was performed by incubating the nuclear lysates first with either NFkB
p50 or p65 antibody for 30 min and then with radiolabelled gastrin EMSA probe. The chase was performed using corresponding
unlabelled oligo probes. NE stands for Nuclear Extract. (B) Gastrin promoter occupancy by NFkB heterodimers and other co-factors.
ChIP qPCR analysis was done with anti p50, p65, HDAC1 and p300 antibodies in IL1B (10ng/ml) treated and untreated AGS cells.
(C) NFkB associates with HDAC1 and NCoR on the gastrin promoter to bring about histone methylation. ChIP qPCR analysis was
done with anti NFkB p65, anti-H3K9Me3 and anti-NCoR in IL1B (10ng/ml) treated and untreated AGS cells.
doi: 10.1371/journal.pone.0073409.g004
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regulators function both by coupling sequence specific
transcription factors with basal transcription machinery and
altering chromatin structure via histone modifications [11]. A
few important co-activator proteins include CREB-binding
protein (CBP) and its structural homologue p300 [40], steroid
receptor-coactivator-1 (SRC-1) [41,42], and p300/CBP
associated factor (PCAF) [43]. Since NFkB is commonly known
to associate with p300, we looked for its presence on the
Figure 5.  Modulation of p300 and HDAC1 alters endogenous gastin expression in AGS cells.  (A) Knock down of p300 down
regulates basal expression of endogenous gastrin. AGS cells were incubated with either scrambled control siRNA or with siRNA
against p300 for 48 hr. Cell lysates were prepared and protein estimation was done. Equal amount of total protein was used for
ELISA of Gastrin. (B) HDAC1 functionally attenuates gastrin expression. AGS cells were treated with either IL1B or IL1B along with
TSA or left untreated. Gastrin ELISA was performed with equal amount of protein lysates prepared from these cells. (C) Gastrin
expression is modulated by a stimulus specific alteration between NFkB-p300 and NFkB-HDAC1 recruitment (Upper panel). NFkB
basally activates gastrin expression with p300 as a co-activator (Lower panel). In presence of IL1B there is an increased recruitment
of HDAC1 and divestment of p300 that result in inhibition of gastrin transcription.
doi: 10.1371/journal.pone.0073409.g005
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gastrin promoter. We observed that, in un-stimulated cells,
p300 forms a complex with NFkB p65, and is also present on
the promoter. Knockdown of p300 with siRNA in AGS cells
resulted in lower basal gastrin expression. These observations
strongly suggest that NFkB has a positive role in the basal
transcription of gastrin. However, stimulating the cells with IL1B
shifts the co- regulatory complex and recruits HDAC1 along
with NCoR to gastrin promoter, which participates along with
NFkB p65 to cause gastrin repression. Thus, this study reveals
that the association of different sets of co-factors with NFkB
converts the basal transcriptional activator into a repressor in
the presence of an external stimulus like IL1B (Figure 5C). This
observation is important as it explains the potential role of co-
regulatory proteins in modulating the trans-activation potential
of NFkB. Although it is reported by Zhong et al. [30] that
phoshorylation at S276 of NFkB is crucial for its association
with p300, we did not observe any significant modification on
NFkB p65 other than S536 phosphorylation. Thus, the exact
mechanism of IL1B-mediated change in transcriptional activity
remains elusive. Further investigation is required to find out
whether modifications at other amino acid residues of NFkB
p65, yet largely unexplored, are involved in this process.
Supporting Information
Figure S1.  Modulation of TAK1 and TAB1 expression in
AGS cells. (A) Ectopic expression of pCMVTAK1 and
pCMVTAB1 in AGS cells. AGS cells were co-transfected in a
dose dependent manner with pCMVTAK1 along with its
activator pCMVTAB1 (0.2µg) and immunoblotted with anti
TAK1 and TAB1 antibodies to check for the expression. A
representative blot is shown. (B) siRNA-mediated knock down
of TAK1 in AGS cells. Total RNA was extracted from AGS cells
48 hr after transfection with either TAK1 siRNA (80 nM) or
control siRNA (80 nM). Real time PCR analysis for TAK1
expression was performed in those RNA samples. 18srRNA
was taken as the endogenous control. The graph represents
the mean of relative quantification measured from three
different experiments +/- SD.
(TIF)
Figure S2.  Control experiments of EMSA and ChIP qPCR
analysis. (A) EMSA was performed using consensus NFkB
binding site as the oligo probe and nuclear extracts of AGS
cells treated with IL1B (10ng/ml) for 2 hr. Supershift assay was
performed by incubating the nuclear lysates first with either
NFkB p50 or p65 antibody for 30 min and then with
radiolabelled NFkB consensus oligo. The chase was performed
using corresponding unlabelled oligo probes. NE stands for
Nuclear Extract. (B) ChIP qPCR was done with anti NFkB p50,
p65, HDAC1 and p300 antibodies in IL1B (10 ng/ml) treated
and untreated AGS cells using GAPDH promoter primers to
check for their respective promoter occupancy. (C) ChIP qPCR
was done with anti NFkB p65, anti H3K9Me3 and anti NCoR in
IL1B (10ng/ml) treated and untreated AGS cells using GAPDH
promoter primers to check for their respective promoter
occupancy.
(TIF)
Figure S3.  siRNA-mediated knock down of p300 in AGS
cells. Total RNA was extracted from AGS cells after 48 hr of
transfection with either p300 siRNA (80 nM) or control siRNA
(80 nM). Real time PCR analysis for p300 expression was
performed in those RNA samples. 18srRNA was taken as the
endogenous control. The graph represents the mean of relative
quantification measured from three different experiments +/-
SD.
(TIF)
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